These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3932473)
21. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Kanda N; Tsuchida T; Tamaki K Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928 [TBL] [Abstract][Full Text] [Related]
22. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. Ueda Y; Sakane T; Tsunematsu T J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765 [TBL] [Abstract][Full Text] [Related]
23. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4. Crisi GM; Katz IR; Zucker MB; Thorbecke GJ Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082 [TBL] [Abstract][Full Text] [Related]
24. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
25. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. Sagawa A; Abdou NI J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787 [TBL] [Abstract][Full Text] [Related]
26. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease. Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025 [TBL] [Abstract][Full Text] [Related]
27. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA. Weill BJ; Renoux ML Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851 [TBL] [Abstract][Full Text] [Related]
28. Complement subcomponent C1q stimulates Ig production by human B lymphocytes. Young KR; Ambrus JL; Malbran A; Fauci AS; Tenner AJ J Immunol; 1991 May; 146(10):3356-64. PubMed ID: 1902854 [TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression. Tanaka Y; Saito K; Suzuki H; Eto S; Yamashita U J Immunol; 1989 Sep; 143(5):1584-90. PubMed ID: 2527267 [TBL] [Abstract][Full Text] [Related]
30. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus. Funauchi M; Sugishima H; Minoda M; Horiuchi A J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936 [TBL] [Abstract][Full Text] [Related]
31. Lymphoproliferation and in vitro antibody synthesis in leprosy patients. Yandava CN; Bhutani LK; Sharma AK; Nath I Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):633-40. PubMed ID: 2674302 [TBL] [Abstract][Full Text] [Related]
32. The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. Lipsky PE; Thompson PA; Rosenwasser LJ; Dinarello CA J Immunol; 1983 Jun; 130(6):2708-14. PubMed ID: 6222114 [TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity. Tan P; Pang G; Wilson JD Clin Exp Immunol; 1981 Jun; 44(3):548-54. PubMed ID: 6799237 [TBL] [Abstract][Full Text] [Related]
34. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta. Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682 [TBL] [Abstract][Full Text] [Related]
35. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185 [TBL] [Abstract][Full Text] [Related]
36. Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2. Ralph P; Welte K; Levi E; Nakoinz I; Litcofsky PB; Mertelsmann RH; Moore MA J Immunol; 1984 Apr; 132(4):1858-62. PubMed ID: 6607950 [TBL] [Abstract][Full Text] [Related]
37. Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus. Kumagai S; Sredni B; House S; Steinberg AD; Green I J Immunol; 1982 Jan; 128(1):258-62. PubMed ID: 6976374 [TBL] [Abstract][Full Text] [Related]
38. Enhancement by TP-1, a thymic extract, of pokeweed mitogen-induced differentiation of B cells from normal subjects but not of those from patients with systemic lupus erythematosus. Fiorilli M; Sirianni MC; Pandolfi F; Pucillo LP; Letta T; Aiuti F Thymus; 1982 Jan; 4(1):1-7. PubMed ID: 6977207 [TBL] [Abstract][Full Text] [Related]
39. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus. Kanda N; Watanabe S J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304 [TBL] [Abstract][Full Text] [Related]
40. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. Honda M; Smith HR; Steinberg AD J Clin Invest; 1985 Jul; 76(1):332-40. PubMed ID: 3160728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]